Bicara Therapeutics BCAX Offering costs included in accounts payable and accrued expenses
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept bcax:OfferingCostsIncurredDuringNoncashOrPartialNoncashTransaction.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's offering costs included in accounts payable and accrued expenses.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's offering costs included in accounts payable and accrued expenses?
- Bicara Therapeutics (BCAX) reported offering costs included in accounts payable and accrued expenses of $190K in Q1 2026.